Ryan Jason 4
4 · GeneDx Holdings Corp. · Filed Aug 27, 2025
Insider Transaction Report
Form 4
Ryan Jason
Director
Transactions
- Sale
Class A Common Stock
2025-08-27$129.59/sh−9,890$1,281,690→ 104,784 total(indirect: By Jason Ryan 2024 GRAT) - Sale
Class A Common Stock
2025-08-27$125.07/sh−8,818$1,102,893→ 132,538 total(indirect: By Jason Ryan 2024 GRAT) - Sale
Class A Common Stock
2025-08-27$126.15/sh−8,969$1,131,472→ 123,569 total(indirect: By Jason Ryan 2024 GRAT) - Sale
Class A Common Stock
2025-08-27$127.44/sh−5,443$693,641→ 118,126 total(indirect: By Jason Ryan 2024 GRAT) - Sale
Class A Common Stock
2025-08-27$128.04/sh−3,452$441,997→ 114,674 total(indirect: By Jason Ryan 2024 GRAT) - Sale
Class A Common Stock
2025-08-27$130.01/sh−1,500$195,015→ 103,284 total(indirect: By Jason Ryan 2024 GRAT) - Sale
Class A Common Stock
2025-08-27$129.65/sh−1,150$149,093→ 11,904 total
Footnotes (8)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.50 to $125.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The reporting person is the trustee of the Jason Ryan 2024 GRAT Trust U/A DTD 11/7/2024 (the "GRAT"), and the reporting person is the sole annuitant of the GRAT. The reporting person remains the beneficial owner of the securities held by the GRAT.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.655 to $126.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.76 to $127.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.76 to $128.75 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.89 to $129.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.91 to $130.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.50 to $129.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.